News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dako A/S (Acquired by Agilent Technologies, Inc.) (A) To Collaborate With Merck & Co., Inc. (MRK) On Development Of Companion Diagnostics For Cancer Treatment


1/9/2014 9:39:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GLOSTRUP, Denmark, Jan. 9, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Merck to develop companion diagnostic tests for oncology drugs currently in Merck's development pipeline.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES